Orla Jupp

Dr. Orla Jupp is a Senior Research Associate at Norwich Medical School, University of East Anglia, and a member of the Metabolic Health research group. She maintains an active research profile with significant contributions to rheumatology, biomarker research, and viral diagnostics, particularly in arthritis, Dupuytren's disease, and SARS-CoV-2 variants.

Her research interests include:

• Rheumatology and arthritis research focusing on dietary bioactives and joint health
• Biomarker discovery for surgical outcomes in musculoskeletal conditions
• Viral genomics and epidemiology with emphasis on SARS-CoV-2 variant transmission
• Development and validation of diagnostic testing methodologies

Dr. Jupp's publication record demonstrates a strong translational research approach bridging laboratory findings with clinical applications. Her work on dietary compounds like sulforaphane shows promise for non-pharmaceutical interventions in joint diseases, while her COVID-19 research has directly informed public health responses. The interdisciplinary nature of her work connects nutritional science, molecular biology, and clinical practice across multiple disease areas.

She currently leads or participates in several significant research projects:

• Dietary Screening Bioactives in Arthritis (DISCOVER) Platform (2024-2026), funded by The Kennedy Trust for Rheumatology Research
• Bob Willis donation project (2022-2025), funded by The Bob Willis Fund
• Previous work on Stratifying Dupuytren's disease therapy using metalloproteinases biomarkers (2013-2014)
• Research on Sulforaphane as a dietary isothiocyanate with chondroprotective properties (2013-2014)

Dr. Jupp's laboratory and research team operate at the intersection of metabolic health, rheumatology, and diagnostic development, maintaining extensive collaborations with clinical and basic science researchers across multiple institutions.